Éric Billaud - Concepedia

Author

Éric Billaud

Also Known As

A Asquier-Khati, Billaud, Eric, Billaud,, Éric, C Bernaud, C Brunet, C. Allavena, Camille Bernaud, Clotilde Allavena, E BILLAUD, E Billaud

106

Publications

2.8K

Citations

H-Index

Concepts

All Affiliations

Inserm Sorbonne Université Centre Hospitalier Départemental Vendée Roche (France)Hôtel-Dieu de Paris

ÉB

About

Éric Billaud is an author at Inserm specializing in medicine, clinical epidemiology, and epidemiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	87
2	Public Health	2	2	50
3	Engineering	1	1	107
4	Health Sciences	1	1	23
5	Environmental Engineering	1	1	107

Éric Billaud

Publications

1.1K

Citations

H-Index

Page 1

	Year	Citations
Epidemiology of adult Still's disease: estimate of the incidence by a retrospective study in west France. G Magadur-Joly, Éric Billaud, J Barrier, Annals of the Rheumatic Diseases	1995	307
Phase II Trial of CHOP Plus Rituximab in Patients With HIV-Associated Non-Hodgkin's Lymphoma François Boué, Jean Gabarre, Christian Gisselbrecht, Journal of Clinical Oncology	2006	196
Administration of an anti-interleukin-6 monoclonal antibody to patients with acquired immunodeficiency syndrome and lymphoma: effect on lymphoma growth and on B clinical symptoms D Émilie, John Wijdenes, Christian Gisselbrecht, Blood	1994	120
Detection of Microsporidia and Identification of <i>Enterocytozoon bieneusi</i> in Surface Water by Filtration Followed by Specific PCR. JEAN MARC SPERFEL, Claudine Sarfati, Olivier Liguory, Journal of Eukaryotic Microbiology Specific PcrEngineeringWater MonitoringEnvironmental EngineeringFiltration Followed	1997	107
Dolutegravir Monotherapy Versus Dolutegravir/Abacavir/Lamivudine for Virologically Suppressed People Living With Chronic Human Immunodeficiency Virus Infection: The Randomized Noninferiority MONotherapy of TiviCAY Trial Laurent Hocqueloux, François Raffi, Thiérry Prazuck, Clinical Infectious Diseases	2018	57
[NADIS 2000, development of an electronic medical record for patients infected by HIV, HBV and HCV]. P. Puglièse, Lise Cuzin, P. Enel, PubMed	2003	46
No relationship between high nevirapine plasma concentration and hepatotoxicity in HIV-1-infected patients naive of antiretroviral treatment or switched from protease inhibitors Éric Dailly, Éric Billaud, V�ronique Reliquet, European Journal of Clinical Pharmacology Protease InhibitorsMedicineNeurovirologyAntiretroviral TreatmentAntiviral Drug Development	2004	37
Characteristics trends, mortality and morbidity in persons newly diagnosed HIV positive during the last decade: the profile of new HIV diagnosed people Cyrille Delpierre, V. Lauwers‐Cancès, P. Puglièse, European Journal of Public Health Epidemiologic ResearchLast DecadeCharacteristics TrendsClinical EpidemiologyEpidemiologic Method	2007	33
Factors associated with deaths from suicide in a French nationwide HIV‐infected cohort Maxime Hentzien, André Cabié, P. Puglièse, HIV Medicine	2018	33
Replacement fluids in plasmapheresis: cross-over comparative study Philippe Le Conte, F Nicolás, C. Adjou, Intensive Care Medicine Replacement FluidsFluid MechanicsPhysiologyHematologyPlasma Donation	1997	23

Page 1